Paolo Fabris

Summary

Publications

  1. pmc Pancreatic hyperamylasemia during acute gastroenteritis: incidence and clinical relevance
    G Tositti
    Department of Infectious Diseases San Bortolo Hospital, Vial Rodolfi, 36100 Vicenza, Italy
    BMC Infect Dis 1:18. 2001
  2. ncbi request reprint Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C
    Paolo Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Viale Rodolfi 37, Vicenza, Italy
    J Hepatol 41:644-51. 2004
  3. ncbi request reprint Therapy of chronic hepatitis C virus infection in HIV co-infected people
    P Fabris
    Dept of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Viale Rodolfi, 36100 Vicenza, Italy
    Curr Pharm Des 10:2111-22. 2004
  4. ncbi request reprint Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C
    Paolo Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Viale Rodolfi, Vicenza 36100, Italy
    J Clin Virol 29:160-6. 2004
  5. ncbi request reprint Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy
    P Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    Aliment Pharmacol Ther 18:549-58. 2003
  6. ncbi request reprint Impact of liver steatosis on virological response in [corrected] Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarin
    P Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    Aliment Pharmacol Ther 21:1173-8. 2005
  7. ncbi request reprint Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus
    Paolo Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    J Med Virol 69:339-43. 2003
  8. ncbi request reprint Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle
    P Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    Aliment Pharmacol Ther 23:1161-70. 2006
  9. doi request reprint Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population
    Paolo Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    J Clin Gastroenterol 42:527-32. 2008
  10. ncbi request reprint Serum pepsinogen and gastrin levels in HIV-positive patients: relationship with CD4+ cell count and Helicobacter pylori infection
    P Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    Aliment Pharmacol Ther 16:807-11. 2002

Collaborators

Detail Information

Publications26

  1. pmc Pancreatic hyperamylasemia during acute gastroenteritis: incidence and clinical relevance
    G Tositti
    Department of Infectious Diseases San Bortolo Hospital, Vial Rodolfi, 36100 Vicenza, Italy
    BMC Infect Dis 1:18. 2001
    ..Many case reports of acute pancreatitis have been reported but, up to now, pancreatic abnormalities during acute gastroenteritis have not been studied prospectively...
  2. ncbi request reprint Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C
    Paolo Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Viale Rodolfi 37, Vicenza, Italy
    J Hepatol 41:644-51. 2004
    ..To evaluate: (1) the relationship between steatosis and either host or viral factors; (2) the correlation between steatosis and fibrosis in patients with CHC...
  3. ncbi request reprint Therapy of chronic hepatitis C virus infection in HIV co-infected people
    P Fabris
    Dept of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Viale Rodolfi, 36100 Vicenza, Italy
    Curr Pharm Des 10:2111-22. 2004
    ..Liver transplantation is being evaluated in many centers. To date the experiences are very limited but encouraging in term of survival rate...
  4. ncbi request reprint Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C
    Paolo Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Viale Rodolfi, Vicenza 36100, Italy
    J Clin Virol 29:160-6. 2004
    ..the frequency and the impact of occult HBV infection in patients with chronic hepatitis C infection is still a matter of some controversy...
  5. ncbi request reprint Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy
    P Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    Aliment Pharmacol Ther 18:549-58. 2003
    ..We suggest that islet cell autoantibodies and glutamic acid decarboxylase autoantibodies should be investigated before and during interferon treatment in order to identify subjects at high risk of developing type 1 diabetes mellitus...
  6. ncbi request reprint Impact of liver steatosis on virological response in [corrected] Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarin
    P Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    Aliment Pharmacol Ther 21:1173-8. 2005
    ..Whether liver steatosis affects sustained virological response in patients with chronic hepatitis C is still under discussion...
  7. ncbi request reprint Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus
    Paolo Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    J Med Virol 69:339-43. 2003
    ..Typical signs and symptoms of cryoglobulinemia do not correlate with the detection of circulating cryoglobulins in HIV and HCV patients...
  8. ncbi request reprint Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle
    P Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    Aliment Pharmacol Ther 23:1161-70. 2006
    ..To assess how much patients with hepatitis C virus infection know about their condition and what impact it has on their lifestyle...
  9. doi request reprint Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population
    Paolo Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    J Clin Gastroenterol 42:527-32. 2008
    ....
  10. ncbi request reprint Serum pepsinogen and gastrin levels in HIV-positive patients: relationship with CD4+ cell count and Helicobacter pylori infection
    P Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    Aliment Pharmacol Ther 16:807-11. 2002
    ..The relationship between serum parameters of gastric function and Helicobacter pylori infection in human immunodeficiency virus (HIV)-positive patients is almost unknown...
  11. ncbi request reprint Impact of occult HBV infection in HIV/HCV co-infected patients: HBV-DNA detection in liver specimens and in serum samples
    Paolo Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    Curr HIV Res 6:173-9. 2008
    ..Occult B infection is relatively frequent in HIV/HCV co-infected patients, and is underestimated by common HBV-DNA serological assays. However, it doesn't seem to exert a relevant impact...
  12. ncbi request reprint Interferon alfa-2b alone or in combination with ketoprofen as treatment for interferon-naive chronic hepatitis C patients
    P Fabris
    Department of Infectious Diseases, S Bortolo Hospital, Vicenza, Italy
    Aliment Pharmacol Ther 13:1329-34. 1999
    ..Non-steroidal anti-inflammatory drugs may amplify the anti-viral effect of alpha-interferon in vitro but in vivo data are still controversial...
  13. ncbi request reprint Chlamydia pneumoniae infection in HIV-positive patients: prevalence and relationship with lipid profile
    G Tositti
    Department of Infectious Diseases and Tropical Medicine, San Bortolo Hospital, Vincenza, Italy
    HIV Med 6:27-32. 2005
    ..The aims of this study were to evaluate the prevalence and impact of Chlamydia pneumoniae infection in HIV-positive patients and to establish the relationship between C. pneumoniae infection and lipid profile...
  14. ncbi request reprint Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection
    P Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    Curr Pharm Des 14:1661-5. 2008
    ..Identifying, in detail therefore, those factors that are responsible for viral control remains an important research goal not only to aid clinical management but also to develop effective treatment and vaccination strategies...
  15. ncbi request reprint Impact of interferon at induction chemotherapy and maintenance treatment for multiple myeloma. Preliminary results of a multicenter study by the Italian non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG)
    G Capnist
    San Bortolo Hospital, Vicenza, Italy
    Acta Oncol 33:527-9. 1994
    ..Up to now, with a median follow-up of 9 months from the evaluation of response, no difference has been recorded between the maintenance and no maintenance groups on relapse rate, neither in good- nor in poor-prognosis patients...
  16. pmc Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection
    F de Lalla
    Department of Infectious Diseases, San Bortolo Hospital, Vicenza, Italy
    Antimicrob Agents Chemother 45:1094-8. 2001
    ..Further clinical studies aimed at precisely defining the role of this approach to this serious complication of diabetes mellitus appear to be justified...
  17. ncbi request reprint Clinical features of bacterial meningitis in Italy: a multicenter prospective observational study
    L Lazzarini
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    J Chemother 20:478-87. 2008
    ..Mortality seemed to be lower in comparison with the literature...
  18. ncbi request reprint Successfull response to alpha 2b interferon plus ribavirin associated with venesectomies in a patient with chronic hepatitis C and genetic hemochromatosis
    Paolo Fabris
    J Gastroenterol Hepatol 18:116-7. 2003
  19. ncbi request reprint Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data
    Gioacchino Leandro
    IRCSS de Bellis, Castellana Grotte, Italy
    Gastroenterology 130:1636-42. 2006
    ..We evaluated the association between steatosis and fibrosis and their common correlates in persons with CHC and in subgroup analyses according to hepatitis C virus (HCV) genotype and body mass index...
  20. ncbi request reprint Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C
    Raffaele Cozzolongo
    Divisione di Gastroenterologia, Ospedale S de Bellis, IRCCS, Castellana Grotte, Bari, Italy
    Eur J Gastroenterol Hepatol 18:689-92. 2006
    ..The patient as a candidate for interferon treatment should therefore be investigated, in addition to thyroid autoimmunity, also for pancreatic autoantibodies before starting therapy...
  21. ncbi request reprint Occult hepatitis B virus infection in HIV/hepatitis C virus co-infected patients
    Paolo Fabris
    AIDS 17:1581-2. 2003
  22. ncbi request reprint Three times weekly versus daily dose alpha-interferon treatment in patients with acute hepatitis C
    Paolo Fabris
    Am J Gastroenterol 97:492-3. 2002
  23. pmc Clinical pharmacokinetics of nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjects
    Mario Regazzi
    Clinical Pharmacokinetic Unit, Department of Pharmacology, IRCCS Policlinico San Matteo, Piazzale Golgi 1, 27100 Pavia, Italy
    Antimicrob Agents Chemother 49:643-9. 2005
    ..Therefore, there may be a role for therapeutic drug monitoring in individualizing the NFV dosage in HIV-HCV-coinfected patients...
  24. ncbi request reprint Lack of higher frequency of the chemokine receptor 5-delta32/delta32 genotype in hepatitis C
    Anna Maria Tommasi
    Department of Surgical and Gastroenterological Sciences, University of Padova, Italy
    J Clin Gastroenterol 40:440-3. 2006
    ..The aim of the present study was to verify whether this mutation occurs in an Italian population with hepatitis C and whether it is an adverse host factor indicative of severity of liver disease and response to antiviral therapy...
  25. ncbi request reprint Waterborne infections in the era of bioterrorism
    Andrea Tramarin
    Lancet 360:1699. 2002
  26. ncbi request reprint Acute hepatitis C: epidemiology, pathogenesis and therapy
    Paolo Fabris
    Curr Pharm Des 14:1644-5. 2008